Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Veliparib in combination with carboplatin for the treatment of triple negative breast cancer

Veliparib in combination with carboplatin for the treatment of triple negative breast cancer

US Patent 9486466 · Granted Nov 8, 2016

Estimated economic value: $206,870,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intraoperative neural monitoring method2024
Methods of treating mixed dyslipidemia and hypertriglycertdemia2022
Methods of preventing the occurrence of cardiovascular events2020
Methods of preventing cardiovascular events in residual risk dyslipidemic popula2020
Active stylus and control circuit thereof2018
Veliparib in combination with carboplatin and paclitaxel for the treatment of no2017
Optical navigation chip used in an optical mouse2016
Optical navigation chip used in an optical mouse2014
Method and arrangement for tracking movement relative to a surface2013
Imaging and navigation arrangement for controlling a cursor2012
Optical mouse with uniform level detection method2011
Treatment of myeoproliferative diseases2010